Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.
about
Toxic myopathiesEffects and side effects associated with the non-nutritional use of tryptophan by humansL-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromesTryptophan Intake in the US Adult Population Is Not Related to Liver or Kidney Function but Is Associated with Depression and Sleep Outcomes.Recent trends in pulmonary arterial hypertensionEpidemiologic studies of environmental agents and systemic autoimmune diseasesHypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndromePathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis rats.A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).Supraphysiologic L-tryptophan elicits cytoskeletal and macromolecular permeability alterations in hamster small intestinal epithelium in vitro.Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophanL-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.Eosinophils: changing perspectives in health and disease.Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis.Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic.Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature.Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD).Abnormalities of the coronary arteries, neural structures and conduction system of the heart observed postmortem in the eosinophilia-myalgia syndrome, with a discussion of comparative findings from the toxic oil syndrome.Brain MRI, lumbar CSF monoamine concentrations, and clinical descriptors of patients with spinocerebellar ataxia mutations.Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndromeToxicology and pharmacokinetics of 1-methyl-d-tryptophan: absence of toxicity due to saturating absorption.Mood effects of the amino acids tryptophan and tyrosine: 'Food for Thought' III.Does 5-hydroxytryptophan cause acute and chronic toxic perturbations in rats?Childhood eosinophilic fasciitis presenting as inflammatory polyarthritis and associated with selective IgA deficiency.The eosinophilia-myalgia syndrome.Possible lansoprazole-induced eosinophilic syndrome.Central and peripheral nervous system involvement in the L-tryptophan associated eosinophilia myalgia syndrome.High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia.Protein source tryptophan versus pharmaceutical grade tryptophan as an efficacious treatment for chronic insomnia.Protein-source tryptophan as an efficacious treatment for social anxiety disorder: a pilot study.Scientific Opinion on the safety and efficacy of L‐tryptophan produced by Escherichia coli CGMCC 7.59 for all animal species based on a dossier submitted by HELM AG on behalf of Meihua Holdings Co. LtdThirteen week toxicity study of dietary l-tryptophan in rats with a recovery period of 5 weeks.The Black Book of Psychotropic Dosing and Monitoring.Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study.Neuropsychological and emotional sequelae of eosinophilia-myalgia syndrome.Pesticide-induced scleroderma and early intensive immunosuppressive treatment.
P2860
Q27007256-05AA7C0A-866F-4D43-BE2D-135B05240910Q27007669-63C08FE7-D9AD-4021-A0AC-D561847338E8Q28363652-C5DD7E76-AAE1-43A4-A5EF-CB91539DD2D8Q30240134-04F3952D-C92F-4797-996A-0A2FA339BE2AQ30475192-323AE10E-2222-4DFC-908B-8A2783DB2588Q33741193-15D0D903-F206-4086-B0D3-2ED501945EA5Q33883542-65025B67-8178-4F80-8A40-47D5849C27B5Q33892462-6CAFFAFA-C8CB-4805-B3B7-6A93AD039258Q34138191-77FE6FEE-A28F-491C-AA4E-A945B194EA00Q34180411-5B19D8E3-B3AC-43E8-AAAC-180E1B8C7B8FQ34195164-56C6FC73-BF23-4B67-8B8F-40E7631C793CQ34264077-72BC5527-0239-4B68-B3DE-0F1E21E187FFQ35170969-A20A6633-D502-4375-B1D0-CADC7549ED0CQ35674181-1C90CBC2-F035-40CA-BED8-ED10190043B8Q35765540-3744B98C-9B68-44D7-B919-EC78FD4F57A2Q35831397-572406D4-A6BE-418C-B3CF-67BEAD2B702AQ36009002-C64EF6ED-EFCE-4B54-94E2-62C358580CD4Q36206063-AE70B2D7-394A-49C4-A1CC-A493E1AC9393Q36647530-1E3470EB-4C50-42E3-9D6F-E12EE873132BQ36899909-F798EE9D-0EE3-4578-B70F-C0B1971C1CC4Q36961666-58BA7A62-D930-443E-B912-282BE3BD9D87Q37347671-BA305C4F-245F-41CE-BF10-D103C48262EAQ37864681-92DEEF67-518D-440B-93DA-3B96B683BBF6Q40361498-36102E08-E8DC-4999-A3EA-73FE34CA221FQ41239478-304018A2-F3CF-4847-99A7-7904FBD2D76AQ42541990-124AF901-095E-4931-B1D3-9506A3ED82A3Q42544609-ACFBBC6C-0407-40AD-9A4D-0AEA871965C7Q44283279-D4234A03-9C8D-4048-9B3D-EEA8E0DA0709Q46555325-BB803882-7AE0-4788-BE1F-97A70BAF069EQ46625713-07C1D610-7B01-49E0-A5FB-1E1B6627E9B3Q46861109-72EE834B-554C-49DC-90B7-54AFB6703F06Q47156745-F9FE3A49-7B4C-4AB7-98CE-D9FBC447E1DEQ47587296-A7773E71-4829-4169-B9FF-DE233FE5BC98Q47642128-618B5A74-B1D7-46A8-B965-B4D2EB5DA24FQ48887047-A0F759EE-19B3-4473-BE14-EEF1D785C66BQ51139956-A73208F5-3222-4A7C-8EAC-0AF589B906C6Q52733991-B03562E8-8146-4C5A-BB96-372BC63BBCD3
P2860
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.
@en
type
label
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.
@en
prefLabel
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.
@en
P2093
P1476
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.
@en
P2093
P304
P356
10.1056/NEJM199003293221301
P407
P577
1990-03-01T00:00:00Z